Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Botulinum toxin for masseter hypertrophy

Esta versión no es la más reciente

ver la versión actual 09 septiembre 2013

Información

DOI:
https://doi.org/10.1002/14651858.CD007510Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 octubre 2008see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Trastornos del movimiento

Copyright:
  1. Copyright © 2008 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Zbys Fedorowicz

    Correspondencia a: UKCC (Bahrain Branch), Ministry of Health, Bahrain, Awali, Bahrain

    [email protected]

  • Mohammed Abdulla Al Muharraqi

    Maxillofacial Surgery Unit, Bahrain Defence Force ‐ Royal Medical Services, Essa Town, Bahrain

  • Jaffer Al Bareeq

    Bahrain Medical Bulletin, Bahrain, Bahrain

  • Reem Al Bareeq

    Division of Urology, Department of Surgery, The University of Western Ontario, London, Canada

  • Mona Nasser

    Department of Health Information, Institute for Quality and Efficiency in Health care, Köln, Germany

Contributions of authors

Zbys Fedorowicz (ZF), Mohammed Al Muharraqi (MAM), Reem Al Bareeq (RAB) and Mona Nasser (MN) will be responsible for:

Organising the retrieval of papers

Writing to authors of papers for additional information

Screening search results

Screening retrieved papers against inclusion criteria

Appraising the quality of papers

Data collection for the review

Extracting data from papers

Obtaining and screening data on unpublished studies.

ZF and Jaffer Al Bareeq (JAB) will enter the data into RevMan.

ZF will be responsible for analysis and interpretation of the data.

All review authors will contribute to writing the review.

ZF, MAM and RAB are responsible for:

Designing the review

Co‐ordinating the review

Data management for the review.

ZF and MAM conceived the idea for the review and are the guarantors for the review.

Declarations of interest

There are no financial conflicts of interest and the authors declare that they do not have any associations with any parties who may have vested interests in the results of this review.

Acknowledgements

The review authors would like to acknowledge the assistance they have received from members of the Cochrane Movement Disorders Group and for the helpful comments on this protocol from the referees.

Version history

Published

Title

Stage

Authors

Version

2013 Sep 09

Botulinum toxin for masseter hypertrophy

Review

Zbys Fedorowicz, Esther J van Zuuren, Jan Schoones

https://doi.org/10.1002/14651858.CD007510.pub3

2009 Jan 21

Botulinum toxin for masseter hypertrophy

Review

Mohammed A Al‐Muharraqi, Zbys Fedorowicz, Jaffer Al Bareeq, Reem Al Bareeq, Mona Nasser

https://doi.org/10.1002/14651858.CD007510.pub2

2008 Oct 08

Botulinum toxin for masseter hypertrophy

Protocol

Zbys Fedorowicz, Mohammed Abdulla Al Muharraqi, Jaffer Al Bareeq, Reem Al Bareeq, Mona Nasser

https://doi.org/10.1002/14651858.CD007510

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.